Effects of PPARγ agonists on cell survival and focal adhesions in a Chinese thyroid carcinoma cell line

Journal of Cellular Biochemistry

Volumn 98, Issue 4, 2006, Pages 1021-1035

  Chen, Ying ^a   Wang, Seu Mei ^a   Wu, Jiahn Chun ^a   Huang, Shih Horng ^b  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b FAR EASTERN MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Apoptosis; Focal adhesion; Necrosis; PPAR agonists

Indexed keywords

CASPASE 3; CIGLITAZONE; CYTOCHROME C; FOCAL ADHESION KINASE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PAXILLIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST; 15 DEOXYPROSTAGLANDIN J2; 15-DEOXYPROSTAGLANDIN J2; 2,4 THIAZOLIDINEDIONE DERIVATIVE; ANTIDIABETIC AGENT; DRUG DERIVATIVE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROSTAGLANDIN D2; TUMOR PROTEIN;

ANOIKIS; APOPTOSIS; ARTICLE; CARCINOMA CELL; CELL DEATH; CELL SURVIVAL; CELL VIABILITY; CHINESE; DEPHOSPHORYLATION; DRUG EFFECT; FOCAL ADHESION; GROWTH INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; THYROID CARCINOMA; TUMOR GROWTH; ASIAN; CARCINOMA; DOSE RESPONSE; DRUG POTENTIATION; METABOLISM; NECROSIS; SIGNAL TRANSDUCTION; THYROID TUMOR; TUMOR CELL LINE;

APOPTOSIS; ASIAN CONTINENTAL ANCESTRY GROUP; CARCINOMA; CELL LINE, TUMOR; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FOCAL ADHESIONS; HUMANS; HYPOGLYCEMIC AGENTS; NECROSIS; NEOPLASM PROTEINS; PPAR GAMMA; PROSTAGLANDIN D2; SIGNAL TRANSDUCTION; THIAZOLIDINEDIONES; THYROID NEOPLASMS;

EID: 33745608468     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.20839     Document Type: Article

References (53)

1. Brown MC, Turner CE. 2002. Roles for the tubulin- and PTP-PEST-binding paxillin LIM domains in cell adhesion and motility. Int J Biochem Cell Biol 34:855-863.
2. Burridge K, Chrzanowska-Wodnicka M. 1996. Focal adhesions, contractility, and signaling. Annu Rev Cell Dev Biol 12:463-518.
3. Burridge K, Path K, Kelly T, Nuckolls G, Turner C. 1988. Focal adhesions: Transmembrane junctions between the extracellular matrix and the cytoskeleton. Ann Rev Cell Biol 4:487-525.
4. Carragher NO, Frame MC. 2004. Focal adhesion and actin dynamics: A place where kinases and proteases meet to promote invasion. Trends Cell Biol 14:241-249.
5. Chen F, Harrison LE. 2005. Ciglitazone induces early cellular proliferation and NF-kappaB transcriptional activity in colon cancer cells through p65 phosphorylation. Int J Biochem Cell Biol 37:645-654.
6. Chung SH, Onoda N, Ishikawa T, Ogisawa K, Takenaka C, Yano Y, Hato F, Hirakawa K. 2002. Peroxisome proliferator-activated receptor gamma activation induces cell cycle arrest via the p53-independent pathway inhuman anaplastic thyroid cancer cells. Jpn J Cancer Res 93: 1358-1365.
7. Datta SR, Brunei A, Greenberg ME. 1999. Cellular survival: A play in three Akts. Genes Dev 13:2905-2927.
8. Davidson D, Veillette A. 2001. PTP-PEST, a scaffold protein tyrosine phosphatase, negatively regulates lymphocyte activation by targeting a unique set of substrates. EMBO J 20:3414-3426.
9. Eibl G, Wente MN, Reber HA, Hines OJ. 2001. Peroxisome proliferator-activated receptor gamma induces pancreatic cancer cell apoptosis. Biochem Biophys Res Commun 287:522-529.
10. Elstner E, Muller C, Koshizuka K, Williamson EA, Park D, Asou H, Shintaku D, Said JW, Hebel D, Koeffler HP. 1998. Ligands for peroxisome proliferator-activated receptor r and retinoid acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice. Proc Natl Acad Sci USA 95:8806-8811.
11. Farrow B, Evers BM. 2003. Activation of PPAR gamma increases PTEN expression in pancreatic cancer cells. Biochem Biophys Res Commun 301:50-53.
12. Faubel S, Edelstein CL. 2005. Caspases as drug targets in ischemic organ injury. Curr Drug Targets Immune Endocr Metabol Disord 5:269-287.
13. Gu J, Tamura M, Pankov R, Danen EH, Takino T, Matsumoto K, Yamada KM. 1999. Shc and FAK differentially regulate cell motility and directionality modulated by PTEN. J Cell Biol 146:389-403.
14. Ha HC, Snyder SH. 1999. Poly(ADP-ribose) polymerase is a mediator of necrotic cell death by ATP depletion. Proc Natl Acad Sci USA 96:13978-13982.
15. Haier J, Nicolson GL. 2002. PTEN regulates tumor cell adhesion of colon carcinoma cells under dynamic conditions of fluid flow. Oncogene 21:1450-1460.
16. Han S, Rivera HN, Roman J. 2005. Peroxisome proliferator-activated receptor-{gamma} ligands inhibit {alpha}5 integrin gene transcription in non-small cell lung carcinoma cells. Am J Respir Cell Mol Biol 35:350-359.
17. Herceg Z, Wang ZQ. 1999. Failure of poly(ADP-ribose) polymerase cleavage by caspases leads to induction of necrosis and enhanced apoptosis. Mol Cell Biol 19:5124-5133.
18. Hungerford JE, Compton ML, Matter BG, Hoffstrom BG, Otey CA. 1996. Inhibition of pp125FAK in cultured fibroblasts results in apoptosis. J Cell Biol 135:1383-1390.
19. Ilic D, Almeida DD, Schlaepfer P, Dazin S, Aizawa S, Damsky CH. 1998. Extracellular matrix survival signals transduced by focal adhesion kinase suppress p53-mediated apoptosis. J Cell Biol 143:547-560.
20. Kawa S, Nikaido T, Unno H, Usuda N, Nakayama K, Kiyosawa K. 2002. Growth inhibition and differentiation of pancreatic cancer cell lines by PPAR gamma ligand troglitazone. Pancreas 24:1-7.
21. Khwaja A, Rodriguez-Viciana P, Wennstrom S, Warne PH, Downward J. 1997. Matrix adhesion and Ras transformation both activate a phosphoinositide 3-OH kinase and protein kinase B/Akt cellular survival pathway. Embo J 16:2783-2793.
22. Kim EJ, Park KS, Chung SY, Sheen YY, Moon DC, Song YS, Kim KS, Song S, Yun YP, Lee MK, Oh KW, Yoon dY, Hong JT. 2003. Peroxisome proliferator-activated receptor-gamma activator 15-deoxy-Delta12,14-prostaglandin J2 inhibits neuroblastoma cell growth through induction of apoptosis: Association with extracellular signal-regulated kinase signal pathway. J Pharmacol Exp Ther 307:505-517.
23. Kubota T, Koshizuka K, Williamson EA, Asou H, Sais JW, Holden S, Miyoshi I, Koeffler HP. 1998. Ligand for peroxisome proliferator-activated receptor r (Troglitazone) has potent antitumor effect against human prostate cancer both in vitro and in vivo. Cancer Res 58:3344-3352.
24. Lee JW, Juliano R. 2004. Mitogenic signal transduction by integrin- and growth factor receptor-mediated pathways. Mol Cells 17:188-202.
25. Lin JD, Chao TC, Weng HF, Huang HS, Ho YS. 1996. Establishment of xenografts and cell lines from well-differentiated human thyroid carcinoma. J Surg Oncol 63:112-118.
26. Martelli ML, Iuliano R, Le Pera I, Sama I, Monaco C, Cammarota S, Kroll T, Chiariotti L, Santoro M, Fusco A. 2002. Inhibitory effects of perxisome proliferator-activated receptor gamma on thyroid carcinoma cell growth. J Clin Endocrinol Metab 87:4728-4735.
27. Ohta K, Endo T, Haraguchi K, Hershman JM, Onaya T. 2001. Ligands for peroxisome proliferator-activated receptor r inhibit growth and induce apoptosis of human papillary thyroid carcinoma cells. J Clin Endocrinol Metab 86:2170-2177.
28. Okano H, Shiraki K, Inoue H, Yamanaka Y, Kawakita T, Saitou Y, Yamaguchi Y, Enokimura N, Yamamoto N, Sugimoto K, Murata K, Nakano T. 2003. 15-deoxy-delta-12-14-PGJ2 regulates apoptosis induction and nuclear factor-kappaB activation via a peroxisome proliferator-activated receptor-gamma-independent mechanism in hepatocellular carcinoma. Lab Invest 83:1529-1539.
29. Patel L, Pass I, Coxon P, Downes CP, Smith SA, Macphee CH. 2001. Tumor suppressor and anti-inflammatory actions of PPARgamma agonists are mediated via upregulation of PTEN. Curr Biol 11:764-768.
30. Pignatelli M, Sanchez-Rodriguez J, Santos A, Perez-Castillo A. 2005. 15-deoxy-Delta-12,14-prostaglandin J2 induces programmed cell death of breast cancer cells by a pleiotropic mechanism. Carcinogenesis 26:81-92.
31. Proskuryakov SY, Konoplyannikov AG, Gabai VL. 2003. Necrosis: A specific form of programmed cell death? Exp Cell Res 283:1-16.
32. Ray DM, Bernstein SH, Phipps RP. 2004. Human multiple myeloma cells express peroxisome proliferator-activated receptor gamma and undergo apoptosis upon exposure to PPARgamma ligands. Clin Immunol 113:203-213.
33. Riedl SJ, Shi Y. 2004. Molecular mechanisms of caspase regulation during apoptosis. Nat Rev Mol Cell Biol 5:897-907.
34. Schaller MD. 2001. Paxillin: A focal adhesion-associated adaptor protein. Oncogene 20:6459-6472.
35. Schlaepfer DD, Mitra SK, Ilic D. 2004. Control of motile and invasive cell phenotypes by focal adhesion kinase. Biochim Biophys Acta 1692:77-102.
36. Shen Y, Schneider G, Cloutier JF, Veillette A, Schaller MD. 1998. Direct association of protein-tyrosine phosphatase PTP-PEST with paxillin. J Biol Chem 273:6474-6481.
37. Shen Y, Lyons P, Cooley M, Davidson D, Veillette A, Salgia R, Griffin JD, Schaller MD. 2000. The noncatalytic domain of protein-tyrosine phosphatase-PEST targets paxillin for dephosphorylation in vivo. J Biol Chem 275:1405-1413.
38. Shen ZN, Nishida K, Doi H, Oohashi T, Hirohata S, Ozaki T, Yoshida A, Ninomiya Y, Inoue H. 2005. Suppression of chondrosarcoma cells by 15-deoxy-Delta 12,14-prostaglandin J2 is associated with altered expression of Bax/ Bcl-xL and p21. Biochem Biophys Res Commun 328:375-382.
39. Strakova N, Ehrmann J, Dzubak P, Bouchal J, Kolar Z. 2004. The synthetic ligand of peroxisome proliferator-activated receptor-gamma ciglitazone affects human glioblastoma cell lines. J Pharmacol Exp Ther 309: 1239-1247.
40. Takahashi N, Okumura T, Motomura W, Fujimoto Y, Kawabata I, Kohgo Y. 1999. Activation of PPARr inhibits cell growth and induced apoptosis in human gastric cancer cells. FEBS Lett 455:135-139.
41. Tamura M, Gu J, Matsumoto K, Aota S, Parsons R, Yamada KM. 1998. Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN. Science 280:1614-1617.
42. Tamura M, Gu J, Danen EH, Takino T, Miyamoto S, Yamada KM. 1999. PTEN interactions with focal adhesion kinase and suppression of the extracellular matrix-dependent phosphatidylinositol 3-kinase/Akt cell survival pathway. J Biol Chem 274:20693-20703.
43. Theocharis S, Margeli A, Vielh P, Kouraklis G. 2004. Peroxisome proliferator-activated receptor-gamma ligands as cell-cycle modulators. Cancer Treat Rev 30:545-554.
44. Tontonoz P, Singer S, Forman BM, Sarref P, Fletcher JA, Fletcher CDM, Brun RP, Mueller E, Altiok S, Oppenhein H, Evans RM, Spiegelman BM. 1997. Terminal differentiaion of human liposarcoma cells induced by ligands for peroxisome proliferator-activated receptor r and the retinoid X receptor. Proc Natl Acad Sci USA 94:237-241.
45. Turner CE. 2000. Paxillin and focal adhesion signalling. Nat Cell Biol 2:E231-E236.
46. van Wijk SJ, Hageman GJ. 2005. Poly(ADP-ribose) polymerase-1 mediated caspase-independent cell death after ischemia/reperfusion. Free Radic Biol Med 39:81-90.
47. Wakino S, Hayashi K, Kanda T, Tatematsu S, Homma K, Yoshioka K, Takamatsu I, Saruta T. 2004. Peroxisome proliferator-activated receptor gamma ligands inhibit Rho/Rho kinase pathway by inducing protein tyrosine phosphatase SHP-2. Circ Res 95:e45-e55.
48. Wang WJ, Kuo JC, Yao CC, Chen RH. 2002. DAP-kinase induces apoptosis by suppressing integrin activity and disrupting matrix survival signals. J Cell Biol 159:169-179.
49. Wang X, Ryter SW, Dai C, Tang ZL, Watkins SC, Yin XM, Song R, Choi AM. 2003. Necrotic cell death in response to oxidant stress involves the activation of the apoptogenic caspase-8/bid pathway. J Biol Chem 278:29184-29191.
50. Webb DJ, Donais K, Whitmore LA, Thomas SM, Turner CE, Parsons JT, Horwitz AF. 2004. FAK-Src signalling through paxillin, ERK and MLCK regulates adhesion disassembly. Nat Cell Biol 6:154-161.
51. Yu SW, Wang H, Dawson TM, Dawson VL. 2003. Poly(ADP-ribose) polymerase-1 and apoptosis inducing factor in neurotoxicity. Neurobiol Dis 14:303-317.
52. Zhan M, Zhao H, Han ZC. 2004. Signalling mechanisms of anoikis. Histol Histopathol 19:973-983.
53. Zhang L, Yu Q, He J, Zha X. 2004. Study of the PTEN gene expression and FAK phosphorylation in human hepatocarcinoma tissues and cell lines. Mol Cell Biochem 262:25-33.